280 related articles for article (PubMed ID: 19052196)
1. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Whitworth C; Bunch JR; Turner JG; Rybak LP; Ramkumar V
J Neurosci; 2008 Dec; 28(49):13056-65. PubMed ID: 19052196
[TBL] [Abstract][Full Text] [Related]
2. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
3. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.
Mukherjea D; Jajoo S; Sheehan K; Kaur T; Sheth S; Bunch J; Perro C; Rybak LP; Ramkumar V
Antioxid Redox Signal; 2011 Mar; 14(6):999-1010. PubMed ID: 20712533
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
5. siRNA-mediated knock-down of NOX3: therapy for hearing loss?
Rybak LP; Mukherjea D; Jajoo S; Kaur T; Ramkumar V
Cell Mol Life Sci; 2012 Jul; 69(14):2429-34. PubMed ID: 22562580
[TBL] [Abstract][Full Text] [Related]
6. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
[TBL] [Abstract][Full Text] [Related]
7. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines.
Kim J; Cho HJ; Sagong B; Kim SJ; Lee JT; So HS; Lee IK; Kim UK; Lee KY; Choo YS
Biochem Biophys Res Commun; 2014 Jun; 449(2):183-9. PubMed ID: 24796665
[TBL] [Abstract][Full Text] [Related]
8. Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss.
Mohri H; Ninoyu Y; Sakaguchi H; Hirano S; Saito N; Ueyama T
J Neurosci; 2021 May; 41(21):4716-4731. PubMed ID: 33849947
[TBL] [Abstract][Full Text] [Related]
9. Transient Receptor Potential Channels and Auditory Functions.
Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
[No Abstract] [Full Text] [Related]
10. Dexamethasone Protects Against Apoptotic Cell Death of Cisplatin-exposed Auditory Hair Cells In Vitro.
Dinh CT; Chen S; Bas E; Dinh J; Goncalves S; Telischi F; Angeli S; Eshraghi AA; Van De Water T
Otol Neurotol; 2015 Sep; 36(9):1566-71. PubMed ID: 26375980
[TBL] [Abstract][Full Text] [Related]
11. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
[TBL] [Abstract][Full Text] [Related]
12. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
13. Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.
Al Aameri RFH; Alanisi EMA; Oluwatosin A; Al Sallami D; Sheth S; Alberts I; Patel S; Rybak LP; Ramkumar V
Front Immunol; 2023; 14():1125948. PubMed ID: 37063917
[TBL] [Abstract][Full Text] [Related]
14. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.
Kopke RD; Liu W; Gabaizadeh R; Jacono A; Feghali J; Spray D; Garcia P; Steinman H; Malgrange B; Ruben RJ; Rybak L; Van de Water TR
Am J Otol; 1997 Sep; 18(5):559-71. PubMed ID: 9303151
[TBL] [Abstract][Full Text] [Related]
15. Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin.
Mukherjea D; Whitworth CA; Nandish S; Dunaway GA; Rybak LP; Ramkumar V
Neuroscience; 2006 May; 139(2):733-40. PubMed ID: 16464536
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DHCR24 increases the cisplatin-induced damage to cochlear hair cells in vitro.
Tian KY; Chang HM; Wang J; Qi MH; Wang WL; Qiu Y; Liang K; Chen FQ; Zha DJ; Qiu JH
Neurosci Lett; 2019 Jul; 706():99-104. PubMed ID: 31091460
[TBL] [Abstract][Full Text] [Related]
18. Protective Effect of Avenanthramide-C on Auditory Hair Cells against Oxidative Stress, Inflammatory Cytokines, and DNA Damage in Cisplatin-Induced Ototoxicity.
Umugire A; Nam YS; Nam YE; Choi YM; Choi SM; Lee S; Cho JH; Cho HH
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769271
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of adenosine receptors in the cochlea by cisplatin.
Ford MS; Nie Z; Whitworth C; Rybak LP; Ramkumar V
Hear Res; 1997 Sep; 111(1-2):143-52. PubMed ID: 9307320
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
